Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma

PURPOSE: This manuscript reports on the occurrence of early and frequent erythrocytosis in advanced hepatocellular carcinoma (HCC) patients treated with lenvatinib. METHODS: A cohort of 23 patients with advanced HCC, treated with this antiangiogenic drug for at least one month, was retrospectively a...

Descripción completa

Detalles Bibliográficos
Autores principales: Legros, Laurence, Pascale, Alina, Guettier, Catherine, Eftekhari, Pirayeh, Merabet, Yasmina Ben, Stang, Maryse, Bossevot, Rachel, Goldschmidt, Emma, Ulusakarya, Ayhan, Morisset, Stephane, Lewin, Maïté, Samuel, Didier, Rosmorduc, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068666/
https://www.ncbi.nlm.nih.gov/pubmed/36961524
http://dx.doi.org/10.1007/s00280-023-04519-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068666/
https://www.ncbi.nlm.nih.gov/pubmed/36961524
http://dx.doi.org/10.1007/s00280-023-04519-6

Ejemplares similares